Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling
Keywords
Crohn's disease
Sclareol
Colonic organoids
Intestinal barrier function
Phytopharmaceutical
AbbreviationsNrf2
nuclear factor erythroid 2-related factor 2
MLCK
myocin light chain kinase
FITC
fluorescein isothiocyanate
5-ASA
5-aminosalicylic acid
TNBS
2,4,6-trinitrobenzenesulfonic acid
Data availability
Data will be made available on request.
© 2024 The Author(s). Published by Elsevier B.V.
留言 (0)